                         SEQUENCE LISTING

<110>  Monash University
       The University of Queensland
 
<120>  CLEC9A antibodies

<130>  53142844AZD

<160>  43    

<170>  PatentIn version 3.5

<210>  1
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  LCDR1 Ab1 humanised anti-Clec9A antibody

<400>  1

Gln Ser Leu Leu His Ser Asp Gly Asn Thr Tyr 
1               5                   10      


<210>  2
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  LCDR2 Ab1 humanised anti-Clec9A antibody

<400>  2

Arg Ile Ser 
1           


<210>  3
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  LCDR3 Ab1 humanised anti-Clec9A antibody

<400>  3

Leu Gln Ser Ser His Phe Pro Pro Thr 
1               5                   


<210>  4
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  HCDR1 Ab1 humanised anti-Clec9A antibody

<400>  4

Gly Phe Thr Phe Asn Asn Tyr Trp 
1               5               


<210>  5
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  HCDR2 Ab1 humanised anti-Clec9A antibody

<400>  5

Ile Thr Thr Ala Ala Gly Gly Thr 
1               5               


<210>  6
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  HCDR3 Ab1 humanised anti-Clec9A antibody

<400>  6

Thr Arg Val Gly Arg Asp Ile Trp Asp Tyr 
1               5                   10  


<210>  7
<211>  113
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  VL Ab1 humanised anti-Clec9A antibody

<400>  7

Asp Ile Val Met Thr Gln Thr Pro Leu Ser Leu Ser Val Thr Pro Gly 
1               5                   10                  15      


Gln Pro Ala Ser Ile Ser Cys Lys Ser Ser Gln Ser Leu Leu His Ser 
            20                  25                  30          


Asp Gly Asn Thr Tyr Leu His Trp Tyr Leu Gln Lys Pro Gly Gln Pro 
        35                  40                  45              


Pro Gln Leu Leu Ile Trp Arg Ile Ser Asn Arg Phe Ser Gly Val Pro 
    50                  55                  60                  


Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Lys Ile 
65                  70                  75                  80  


Ser Arg Val Glu Ala Glu Asp Val Gly Val Tyr Tyr Cys Leu Gln Ser 
                85                  90                  95      


Ser His Phe Pro Pro Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105                 110         


Arg 
    


<210>  8
<211>  117
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  VH Ab1 humanised anti-Clec9A antibody

<400>  8

Glu Val Gln Leu Leu Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Asn Asn Tyr 
            20                  25                  30          


Trp Leu Ala Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Ser Ile Thr Thr Ala Ala Gly Gly Thr Tyr Tyr Pro Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Thr Arg Val Gly Arg Asp Ile Trp Asp Tyr Trp Gly Gln Gly Thr Leu 
            100                 105                 110         


Val Thr Val Ser Ser 
        115         


<210>  9
<211>  33
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  LCDR1 Ab1 humanised anti-Clec9A antibody

<400>  9
cagagcctgc tgcacagcga cggcaatacc tac                                    33


<210>  10
<211>  9
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  LCDR2 Ab1 humanised anti-Clec9A antibody

<400>  10
cggatcagc                                                                9


<210>  11
<211>  27
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  LCDR3 Ab1 humanised anti-Clec9A antibody

<400>  11
ctgcagagca gccactttcc tccaacc                                           27


<210>  12
<211>  24
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  HCDR1 Ab1 humanised anti-Clec9A antibody

<400>  12
ggcttcacct tcaacaatta ttgg                                              24


<210>  13
<211>  24
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  HCDR2 Ab1 humanised anti-Clec9A antibody

<400>  13
attaccaccg ctgccggcgg aacc                                              24


<210>  14
<211>  30
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  HCDR3 Ab1 humanised anti-Clec9A antibody

<400>  14
accagagtgg gcagagacat ctgggattac                                        30


<210>  15
<211>  339
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  VL Ab1 humanised anti-Clec9A antibody

<400>  15
gacatcgtga tgacccaaac acctctgagc ctgagcgtga cacctggaca gcctgccagc       60

atcagctgta aaagcagcca gagcctgctg cacagcgacg gcaataccta cctgcactgg      120

tatctgcaga agcccggaca gcctcctcag ctgctgattt ggcggatcag caacagattc      180

agcggcgtgc ccgatagatt ttctggctct ggcagcggca ccgacttcac cctgaagatt      240

agcagagtgg aagccgagga cgtgggcgtg tactactgtc tgcagagcag ccactttcct      300

ccaacctttg gcggaggcac caaggtggaa atcaagaga                             339


<210>  16
<211>  351
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  VH Ab1 humanised anti-Clec9A antibody

<400>  16
gaggtgcagc tgcttgaatc tggcggagga cttgttcagc ctggcggctc tctgagactg       60

tcttgtgccg ccagcggctt caccttcaac aattattggc tggcctgggt ccgacaggcc      120

cctggaaaag gacttgagtg ggtcgcctct attaccaccg ctgccggcgg aacctactat      180

cccgattctg tgaagggcag attcaccatc agccgggaca acagcaagaa caccctgtac      240

ctgcagatga acagcctgag agccgaggac accgccgtgt actactgtac cagagtgggc      300

agagacatct gggattactg gggccagggc accctggtta cagtgtctag c               351


<210>  17
<211>  26
<212>  PRT
<213>  Artificial Sequence

<220>
<223>   LFR1 Ab1 humanised anti-Clec9A antibody

<400>  17

Asp Ile Val Met Thr Gln Thr Pro Leu Ser Leu Ser Val Thr Pro Gly 
1               5                   10                  15      


Gln Pro Ala Ser Ile Ser Cys Lys Ser Ser 
            20                  25      


<210>  18
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>   LFR2 Ab1 humanised anti-Clec9A antibody

<400>  18

Leu His Trp Tyr Leu Gln Lys Pro Gly Gln Pro Pro Gln Leu Leu Ile 
1               5                   10                  15      


Trp 
    


<210>  19
<211>  36
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  LFR3 Ab1 humanised anti-Clec9A antibody

<400>  19

Asn Arg Phe Ser Gly Val Pro Asp Arg Phe Ser Gly Ser Gly Ser Gly 
1               5                   10                  15      


Thr Asp Phe Thr Leu Lys Ile Ser Arg Val Glu Ala Glu Asp Val Gly 
            20                  25                  30          


Val Tyr Tyr Cys 
        35      


<210>  20
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>   LFR4 Ab1 humanised anti-Clec9A antibody

<400>  20

Phe Gly Gly Gly Thr Lys Val Glu Ile Lys Arg 
1               5                   10      


<210>  21
<211>  25
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  HFR1 Ab1 humanised anti-Clec9A antibody

<400>  21

Glu Val Gln Leu Leu Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser 
            20                  25  


<210>  22
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  HFR2 Ab1 humanised anti-Clec9A antibody

<400>  22

Leu Ala Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val Ala 
1               5                   10                  15      


Ser 
    


<210>  23
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  HFR3 Ab1 humanised anti-Clec9A antibody

<400>  23

Tyr Tyr Pro Asp Ser Val Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn 
1               5                   10                  15      


Ser Lys Asn Thr Leu Tyr Leu Gln Met Asn Ser Leu Arg Ala Glu Asp 
            20                  25                  30          


Thr Ala Val Tyr Tyr Cys 
        35              


<210>  24
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  HFR4 Ab1 humanised anti-Clec9A antibody

<400>  24

Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
1               5                   10      


<210>  25
<211>  78
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  LFR1 Ab1 humanised anti-Clec9A antibody

<400>  25
gacatcgtga tgacccaaac acctctgagc ctgagcgtga cacctggaca gcctgccagc       60

atcagctgta aaagcagc                                                     78


<210>  26
<211>  51
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  LFR2 Ab1 humanised anti-Clec9A antibody

<400>  26
ctgcactggt atctgcagaa gcccggacag cctcctcagc tgctgatttg g                51


<210>  27
<211>  108
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  LFR3 Ab1 humanised anti-Clec9A antibody

<400>  27
aacagattca gcggcgtgcc cgatagattt tctggctctg gcagcggcac cgacttcacc       60

ctgaagatta gcagagtgga agccgaggac gtgggcgtgt actactgt                   108


<210>  28
<211>  33
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  LFR4 Ab1 humanised anti-Clec9A antibody

<400>  28
tttggcggag gcaccaaggt ggaaatcaag aga                                    33


<210>  29
<211>  75
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  HFR1 Ab1 humanised anti-Clec9A antibody

<400>  29
gaggtgcagc tgcttgaatc tggcggagga cttgttcagc ctggcggctc tctgagactg       60

tcttgtgccg ccagc                                                        75


<210>  30
<211>  51
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  HFR2 Ab1 humanised anti-Clec9A antibody

<400>  30
ctggcctggg tccgacaggc ccctggaaaa ggacttgagt gggtcgcctc t                51


<210>  31
<211>  114
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  HFR3 Ab1 humanised anti-Clec9A antibody

<400>  31
tactatcccg attctgtgaa gggcagattc accatcagcc gggacaacag caagaacacc       60

ctgtacctgc agatgaacag cctgagagcc gaggacaccg ccgtgtacta ctgt            114


<210>  32
<211>  33
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  HFR4 Ab1 humanised anti-Clec9A antibody

<400>  32
tggggccagg gcaccctggt tacagtgtct agc                                    33


<210>  33
<211>  463
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Heavy chain Ab1 humanised anti-Clec9A antibody

<400>  33

Met Asp Ile Arg Leu Ser Leu Val Phe Leu Val Leu Phe Ile Lys Gly 
1               5                   10                  15      


Val Gln Cys Glu Val Gln Leu Leu Glu Ser Gly Gly Gly Leu Val Gln 
            20                  25                  30          


Pro Gly Gly Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe 
        35                  40                  45              


Asn Asn Tyr Trp Leu Ala Trp Val Arg Gln Ala Pro Gly Lys Gly Leu 
    50                  55                  60                  


Glu Trp Val Ala Ser Ile Thr Thr Ala Ala Gly Gly Thr Tyr Tyr Pro 
65                  70                  75                  80  


Asp Ser Val Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn 
                85                  90                  95      


Thr Leu Tyr Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val 
            100                 105                 110         


Tyr Tyr Cys Thr Arg Val Gly Arg Asp Ile Trp Asp Tyr Trp Gly Gln 
        115                 120                 125             


Gly Thr Leu Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser Val 
    130                 135                 140                 


Phe Pro Leu Ala Pro Cys Ser Arg Ser Thr Ser Glu Ser Thr Ala Ala 
145                 150                 155                 160 


Leu Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val Ser 
                165                 170                 175     


Trp Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala Val 
            180                 185                 190         


Leu Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val Pro 
        195                 200                 205             


Ser Ser Ser Leu Gly Thr Lys Thr Tyr Thr Cys Asn Val Asp His Lys 
    210                 215                 220                 


Pro Ser Asn Thr Lys Val Asp Lys Arg Val Glu Ser Lys Tyr Gly Pro 
225                 230                 235                 240 


Pro Cys Pro Pro Cys Pro Ala Pro Glu Phe Glu Gly Gly Pro Ser Val 
                245                 250                 255     


Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile Ser Arg Thr 
            260                 265                 270         


Pro Glu Val Thr Cys Val Val Val Asp Val Ser Gln Glu Asp Pro Glu 
        275                 280                 285             


Val Gln Phe Asn Trp Tyr Val Asp Gly Val Glu Val His Asn Ala Lys 
    290                 295                 300                 


Thr Lys Pro Arg Glu Glu Gln Phe Asn Ser Thr Tyr Arg Val Val Ser 
305                 310                 315                 320 


Val Leu Thr Val Leu His Gln Asp Trp Leu Asn Gly Lys Glu Tyr Lys 
                325                 330                 335     


Cys Lys Val Ser Asn Lys Gly Leu Pro Ser Ser Ile Glu Lys Thr Ile 
            340                 345                 350         


Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln Val Tyr Thr Leu Pro 
        355                 360                 365             


Pro Ser Gln Glu Glu Met Thr Lys Asn Gln Val Ser Leu Thr Cys Leu 
    370                 375                 380                 


Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu Trp Glu Ser Asn 
385                 390                 395                 400 


Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro Pro Val Leu Asp Ser 
                405                 410                 415     


Asp Gly Ser Phe Phe Leu Tyr Ser Arg Leu Thr Val Asp Lys Ser Arg 
            420                 425                 430         


Trp Gln Glu Gly Asn Val Phe Ser Cys Ser Val Met His Glu Ala Leu 
        435                 440                 445             


His Asn His Tyr Thr Gln Lys Ser Leu Ser Leu Ser Leu Gly Lys 
    450                 455                 460             


<210>  34
<211>  238
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Light chain Ab1 humanised anti-Clec9A antibody

<400>  34

Met Lys Trp Pro Val Arg Leu Leu Val Leu Phe Phe Trp Ile Pro Val 
1               5                   10                  15      


Ser Arg Gly Asp Ile Val Met Thr Gln Thr Pro Leu Ser Leu Ser Val 
            20                  25                  30          


Thr Pro Gly Gln Pro Ala Ser Ile Ser Cys Lys Ser Ser Gln Ser Leu 
        35                  40                  45              


Leu His Ser Asp Gly Asn Thr Tyr Leu His Trp Tyr Leu Gln Lys Pro 
    50                  55                  60                  


Gly Gln Pro Pro Gln Leu Leu Ile Trp Arg Ile Ser Asn Arg Phe Ser 
65                  70                  75                  80  


Gly Val Pro Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr 
                85                  90                  95      


Leu Lys Ile Ser Arg Val Glu Ala Glu Asp Val Gly Val Tyr Tyr Cys 
            100                 105                 110         


Leu Gln Ser Ser His Phe Pro Pro Thr Phe Gly Gly Gly Thr Lys Val 
        115                 120                 125             


Glu Ile Lys Arg Thr Val Ala Ala Pro Ser Val Phe Ile Phe Pro Pro 
    130                 135                 140                 


Ser Asp Glu Gln Leu Lys Ser Gly Thr Ala Ser Val Val Cys Leu Leu 
145                 150                 155                 160 


Asn Asn Phe Tyr Pro Arg Glu Ala Lys Val Gln Trp Lys Val Asp Asn 
                165                 170                 175     


Ala Leu Gln Ser Gly Asn Ser Gln Glu Ser Val Thr Glu Gln Asp Ser 
            180                 185                 190         


Lys Asp Ser Thr Tyr Ser Leu Ser Ser Thr Leu Thr Leu Ser Lys Ala 
        195                 200                 205             


Asp Tyr Glu Lys His Lys Val Tyr Ala Cys Glu Val Thr His Gln Gly 
    210                 215                 220                 


Leu Ser Ser Pro Val Thr Lys Ser Phe Asn Arg Gly Glu Cys 
225                 230                 235             


<210>  35
<211>  27
<212>  PRT
<213>  Homo sapiens

<400>  35

Arg Trp Leu Trp Gln Asp Gly Ser Ser Pro Ser Pro Gly Leu Leu Pro 
1               5                   10                  15      


Ala Glu Arg Ser Gln Ser Ala Asn Gln Val Cys 
            20                  25          


<210>  36
<211>  241
<212>  PRT
<213>  Homo sapiens

<400>  36

Met His Glu Glu Glu Ile Tyr Thr Ser Leu Gln Trp Asp Ser Pro Ala 
1               5                   10                  15      


Pro Asp Thr Tyr Gln Lys Cys Leu Ser Ser Asn Lys Cys Ser Gly Ala 
            20                  25                  30          


Cys Cys Leu Val Met Val Ile Ser Cys Val Phe Cys Met Gly Leu Leu 
        35                  40                  45              


Thr Ala Ser Ile Phe Leu Gly Val Lys Leu Leu Gln Val Ser Thr Ile 
    50                  55                  60                  


Ala Met Gln Gln Gln Glu Lys Leu Ile Gln Gln Glu Arg Ala Leu Leu 
65                  70                  75                  80  


Asn Phe Thr Glu Trp Lys Arg Ser Cys Ala Leu Gln Met Lys Tyr Cys 
                85                  90                  95      


Gln Ala Phe Met Gln Asn Ser Leu Ser Ser Ala His Asn Ser Ser Pro 
            100                 105                 110         


Cys Pro Asn Asn Trp Ile Gln Asn Arg Glu Ser Cys Tyr Tyr Val Ser 
        115                 120                 125             


Glu Ile Trp Ser Ile Trp His Thr Ser Gln Glu Asn Cys Leu Lys Glu 
    130                 135                 140                 


Gly Ser Thr Leu Leu Gln Ile Glu Ser Lys Glu Glu Met Asp Phe Ile 
145                 150                 155                 160 


Thr Gly Ser Leu Arg Lys Ile Lys Gly Ser Tyr Asp Tyr Trp Val Gly 
                165                 170                 175     


Leu Ser Gln Asp Gly His Ser Gly Arg Trp Leu Trp Gln Asp Gly Ser 
            180                 185                 190         


Ser Pro Ser Pro Gly Leu Leu Pro Ala Glu Arg Ser Gln Ser Ala Asn 
        195                 200                 205             


Gln Val Cys Gly Tyr Val Lys Ser Asn Ser Leu Leu Ser Ser Asn Cys 
    210                 215                 220                 


Ser Thr Trp Lys Tyr Phe Ile Cys Glu Lys Tyr Ala Leu Arg Ser Ser 
225                 230                 235                 240 


Val 
    


<210>  37
<211>  113
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  VL rat anti-Clec9A antibody

<400>  37

Glu Ile Leu Met Thr Gln Thr Pro Val Ser Leu Pro Val Ser Leu Gly 
1               5                   10                  15      


Gly Gln Val Ser Phe Ser Cys Arg Ser Ser Gln Ser Leu Leu His Ser 
            20                  25                  30          


Asp Gly Asn Thr Tyr Leu His Trp Tyr Leu Gln Lys Pro Gly Gln Ser 
        35                  40                  45              


Pro Gln Leu Leu Ile Trp Arg Ile Ser Asn Arg Phe Ser Gly Val Pro 
    50                  55                  60                  


Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Lys Ile 
65                  70                  75                  80  


Ser Arg Val Glu Pro Glu Asp Leu Gly Val Tyr Tyr Cys Leu Gln Ser 
                85                  90                  95      


Ser His Phe Pro Pro Thr Phe Gly Gly Gly Thr Asn Leu Glu Leu Lys 
            100                 105                 110         


Arg 
    


<210>  38
<211>  117
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  VH human/rat chimeric anti-Clec9A antibody

<400>  38

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Lys Leu Ser Cys Val Ala Ser Gly Phe Thr Phe Asn Asn Tyr 
            20                  25                  30          


Trp Leu Ala Trp Ile Arg Gln Ala Pro Arg Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Ser Ile Thr Thr Ala Ala Gly Gly Thr Tyr Tyr Pro Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala Lys Ser Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Thr Ser Glu Asp Thr Ala Thr Tyr Tyr Cys 
                85                  90                  95      


Thr Arg Val Gly Arg Asp Ile Trp Asp Tyr Trp Gly Gln Gly Val Val 
            100                 105                 110         


Val Thr Val Ser Ser 
        115         


<210>  39
<211>  51
<212>  PRT
<213>  Homo sapiens

<400>  39

Ser Ser Gly Gln Ala Arg Met Phe Pro Asn Ala Pro Tyr Leu Pro Ser 
1               5                   10                  15      


Ser Gln Leu Glu Cys Met Thr Trp Asn Gln Met Asn Leu Gly Ala Cys 
            20                  25                  30          


Asn Lys Arg Tyr Phe Lys Leu Ser His Leu Gln Met His Ser Arg Lys 
        35                  40                  45              


His Thr Gly 
    50      


<210>  40
<211>  247
<212>  PRT
<213>  SARS-CoV-2 RBD

<400>  40

Lys Ser Phe Thr Val Glu Lys Gly Ile Tyr Gln Thr Ser Asn Phe Arg 
1               5                   10                  15      


Val Gln Pro Thr Glu Ser Ile Val Arg Phe Pro Asn Ile Thr Asn Leu 
            20                  25                  30          


Cys Pro Phe Gly Glu Val Phe Asn Ala Thr Arg Phe Ala Ser Val Tyr 
        35                  40                  45              


Ala Trp Asn Arg Lys Arg Ile Ser Asn Cys Val Ala Asp Tyr Ser Val 
    50                  55                  60                  


Leu Tyr Asn Ser Ala Ser Phe Ser Thr Phe Lys Cys Tyr Gly Val Ser 
65                  70                  75                  80  


Pro Thr Lys Leu Asn Asp Leu Cys Phe Thr Asn Val Tyr Ala Asp Ser 
                85                  90                  95      


Phe Val Ile Arg Gly Asp Glu Val Arg Gln Ile Ala Pro Gly Gln Thr 
            100                 105                 110         


Gly Lys Ile Ala Asp Tyr Asn Tyr Lys Leu Pro Asp Asp Phe Thr Gly 
        115                 120                 125             


Cys Val Ile Ala Trp Asn Ser Asn Asn Leu Asp Ser Lys Val Gly Gly 
    130                 135                 140                 


Asn Tyr Asn Tyr Leu Tyr Arg Leu Phe Arg Lys Ser Asn Leu Lys Pro 
145                 150                 155                 160 


Phe Glu Arg Asp Ile Ser Thr Glu Ile Tyr Gln Ala Gly Ser Thr Pro 
                165                 170                 175     


Cys Asn Gly Val Glu Gly Phe Asn Cys Tyr Phe Pro Leu Gln Ser Tyr 
            180                 185                 190         


Gly Phe Gln Pro Thr Asn Gly Val Gly Tyr Gln Pro Tyr Arg Val Val 
        195                 200                 205             


Val Leu Ser Phe Glu Leu Leu His Ala Pro Ala Thr Val Cys Gly Pro 
    210                 215                 220                 


Lys Lys Ser Thr Asn Leu Val Lys Asn Lys Cys Val Asn Phe Asn Phe 
225                 230                 235                 240 


Asn Gly Leu Thr Gly Thr Gly 
                245         


<210>  41
<211>  94
<212>  PRT
<213>  Homo sapiens

<400>  41

Leu Leu Glu Phe Tyr Leu Ala Met Pro Phe Ala Thr Pro Met Glu Ala 
1               5                   10                  15      


Glu Leu Ala Arg Arg Ser Leu Ala Gln Asp Ala Pro Pro Leu Pro Val 
            20                  25                  30          


Pro Gly Val Leu Leu Lys Glu Phe Thr Val Ser Gly Asn Ile Leu Thr 
        35                  40                  45              


Ile Arg Leu Thr Ala Ala Asp His Arg Gln Leu Gln Leu Ser Ile Ser 
    50                  55                  60                  


Ser Cys Leu Gln Gln Leu Ser Leu Leu Met Trp Ile Thr Gln Cys Phe 
65                  70                  75                  80  


Leu Pro Val Phe Leu Ala Gln Pro Pro Ser Gly Gln Arg Arg 
                85                  90                  


<210>  42
<211>  81
<212>  PRT
<213>  Influenza A

<400>  42

Met Ser Leu Leu Thr Glu Val Glu Thr Pro Ile Arg Asn Glu Trp Gly 
1               5                   10                  15      


Cys Arg Cys Asn Asp Ser Ser Asp Gly Gly Gly Met Ser Leu Leu Thr 
            20                  25                  30          


Glu Val Glu Thr Pro Ile Arg Asn Glu Trp Gly Cys Arg Cys Asn Asp 
        35                  40                  45              


Ser Ser Asp Gly Gly Gly Met Ser Leu Leu Thr Glu Val Glu Thr Pro 
    50                  55                  60                  


Ile Arg Asn Glu Trp Gly Cys Arg Cys Asn Asp Ser Ser Asp Gly Gly 
65                  70                  75                  80  


Gly 
    


<210>  43
<211>  113
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  VL human/rat chimeric anti-Clec9A antibody

<400>  43

Glu Ile Leu Met Thr Gln Thr Pro Val Ser Leu Pro Val Ser Leu Gly 
1               5                   10                  15      


Gly Gln Val Ser Phe Ser Cys Arg Ser Ser Gln Ser Leu Leu His Ser 
            20                  25                  30          


Asp Gly Asn Thr Tyr Leu His Trp Tyr Leu Gln Lys Pro Gly Gln Ser 
        35                  40                  45              


Pro Gln Leu Leu Ile Trp Arg Ile Ser Asn Arg Phe Ser Gly Val Pro 
    50                  55                  60                  


Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Lys Ile 
65                  70                  75                  80  


Ser Arg Val Glu Pro Glu Asp Leu Gly Val Tyr Tyr Cys Leu Gln Ser 
                85                  90                  95      


Ser His Phe Pro Pro Thr Phe Gly Gly Gly Thr Asn Leu Glu Ile Lys 
            100                 105                 110         


Arg 
    


